Okuyama, Yuki
Hirawa, Nobuhito
Fujita, Megumi
Fujiwara, Akira
Ehara, Yosuke
Yatsu, Keisuke
Sumida, Koichiro
Kagimoto, Minako
Katsumata, Mari
Kobayashi, Yusuke
Saka, Sanae
Umemura, Satoshi
Tamura, Kouichi
Article History
Received: 3 March 2017
Revised: 21 June 2017
Accepted: 27 July 2017
First Online: 19 October 2017
Competing interests
: NH received a research grant from Pfizer, and SU received lecture fees from Takeda, Behringer, Daiichi-Sankyo, MSD, Shionogi, and Kyowa Hakko Kirin, received manuscript fees from Sunmark publisher, and received scholarship donations from Takeda, Dainippon-Sumitomo, Pfizer, Asteras, Daiichi-Sankyo, Behringer, Novartis, Astorazeneka, Kowa, Shionogi, and MSD. KT received research grants from AstraZeneca, Ono Pharmaceutical, and Tsumura. NH and SU have been named as the inventors on a patent based on work on ATP2B1 SNPs and hypertension. The remaining authors declare no conflict of interest.